PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.77%
Revenue growth at 50-75% of META's 10.80%. Martin Whitman would worry about competitiveness or product relevance.
6.31%
Gross profit growth at 50-75% of META's 9.85%. Martin Whitman would question if cost structure or brand is lagging.
88.33%
EBIT growth above 1.5x META's 16.38%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
88.33%
Operating income growth above 1.5x META's 16.38%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
91.03%
Net income growth above 1.5x META's 20.93%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
96.00%
EPS growth above 1.5x META's 20.90%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
92.00%
Diluted EPS growth above 1.5x META's 20.45%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.14%
Share count expansion well above META's 0.21%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.03%
Diluted share reduction more than 1.5x META's 0.17%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
33.35%
OCF growth above 1.5x META's 14.33%. David Dodd would confirm a clear edge in underlying cash generation.
38.54%
FCF growth above 1.5x META's 11.67%. David Dodd would verify if the firm’s strategic investments yield superior returns.
489.25%
10Y revenue/share CAGR at 50-75% of META's 800.05%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
86.23%
5Y revenue/share CAGR under 50% of META's 570.42%. Michael Burry would suspect a significant competitive gap or product weakness.
64.15%
3Y revenue/share CAGR under 50% of META's 187.17%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
442.86%
10Y OCF/share CAGR at 50-75% of META's 801.72%. Martin Whitman might fear a structural deficiency in operational efficiency.
133.13%
Below 50% of META's 1908.01%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
60.85%
3Y OCF/share CAGR under 50% of META's 337.30%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
464.86%
Below 50% of META's 1622.83%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
192.54%
Below 50% of META's 6631.35%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
140.04%
Below 50% of META's 422.36%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
570.46%
Equity/share CAGR of 570.46% while META is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
118.36%
Below 50% of META's 311.55%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
55.27%
Below 50% of META's 198.60%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.71%
AR growth is negative/stable vs. META's 13.52%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
92.21%
Inventory growth of 92.21% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
6.11%
Asset growth at 75-90% of META's 6.98%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
5.80%
75-90% of META's 6.89%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
0.23%
Debt growth of 0.23% while META is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
0.79%
R&D dropping or stable vs. META's 6.93%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
0.87%
We expand SG&A while META cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.